OBJECTIVES: Inadequate treatment of haemophiliacs leads to high rate of chronic arthropathy, high number of transfusiontransmitted diseases and poor social integration. The objectives of our study were to measure HRQOL and utilities in haemophilia patients and to evaluate the influence of haemophilia severity, patient's age and socio-professional status on HRQOL and utilities. METHODS: We used SF-36 and EQ-5D questionnaires in 100 haemophilia patients with severe (66), moderate (18) and mild form (16 cases), registered and treated in Haemophilia Center Timisoara. Mean age of the patients was 23.14 years. We considered two age groups: 16-24 years (60 patients) and 25-34 years (40 patients). Seventeen of the haemophiliacs were schoolboys, 13-university students, 19-employees and 51 were handicapped with social support. RESULTS: Compared with Romanian general population norms (available only for SF-36 questionnaire) HRQOL is affected in haemophilia patients in both age groups, although age was not a strong predictor of HRQOL or utilities. Haemophilia severity was found to have a strong influence on HRQOL and utilities. Regarding the socio-professional status, handicapped with social support had the lowest HRQOL scores and utilities values. CONCLUSIONS: Our results confirm the need to develop special long-term national programs in order to improve haemophilia treatment, to reduce the number and the severity of complications, to offer a better social integration of the patients and to improve their quality of life. To establish which characteristics patients consider important in prophylaxis, and if cost of treatment could influence their preferences. METHODS: A focus group identified five characteristics: type of product (plasma-derived vs. recombinant), infusions frequency, hemorrhages frequency, possibility to do vigorous physical activities, possibility to do usual activities. Patients gave their opinion rating each characteristic from zero (not important) to 100 (very important). Scenarios describing hypothetical treatment modalities were administered to patients who were asked to chose one for each couple presented. The characteristic "cost", expressed as increase in health care taxes, was then added in each scenario and patients were invited to make again their choices. RESULTS: Fifteen people, 13 adult patients and 2 parents, were enrolled. The characteristic considered most important was "usual activities" (median = 95), followed by "hemorrhages frequency" (86), "infusions frequency" (81), "type of product" (76), "vigorous physical activities" (69) and finally "cost" (50). Almost all patients did not suggest other important characteristics. Eleven patients (73%) changed at least one choice when "cost" was present. CON-CLUSIONS: This pilot study allowed us to identify aspects considered by hemophilia patients as important in prophylaxis. These results will help us to design a Conjoint Analysis aimed at evaluating utilities and monetary value of these aspects. Italian Hemophilia Care Centers. Information on demographics, clinical status, health-care resources consumption was prospectively collected. QoL was investigated by means of the generic instruments EQ-5D and SF-36. RESULTS: With the EQ-profile the majority of patients reported some/moderate problems in domains "pain/discomfort" (72%), "mobility" (66%) and "usual activities" (54%). Around one third declared some/moderate problems with "anxiety/depression" (34%) and "self-care" (32%). No more than 6% of patients reported severe problems in any of the domains. The EQ-Visual Analogue Scale (VAS), measuring the global health state perception, was normally distributed, with a median value of 66 (30-95). The SF-Mental Component Summary (MCS) had a median value of 52.8 (15.5-68.1), while the SF-Physical Component Summary (PCS) had a median value of 35.2 (15.2-55.0). A strong association was found between orthopedic status and global HR-QoL (EQ-VAS, Pearson's r = 0.56, p < 0.01). In particular, the physical component of HR-QoL was the most influenced by the patients' orthopedic status (Physical Component Summary, Pearson's r = -0.359, p < 0.01). Other clinical parameters, in particular inhibitor titers and bleeding frequency, were not associated with patients' HR-QoL. CONCLUSIONS: Modern health care strategies aimed at treating or, better, at preventing hemophilic arthropathy should be considered to improve quality of life in inhibitor patients. Patients were asked to make choices between variables of replacement therapy such as perceived viral safety, risk of inhibitor development, infusion frequency on prophylaxis, pharmaceutical dosage form, way of distribution and price. RESULTS: The value of each characteristic was indicated by its monetary value: the monetary value for perceived viral safety was greater for moderate (2547€) compared to severe hemo-
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PDB1 ASSOCIATION OF PATIENTS' KNOWLEDGE AND ADHERENCE TO MEDICAL ADVICE TO GLYCAEMIC CONTROL IN THE MANAGEMENT OF DIABETES MELLITUS
Lee VW, Sin KK,Yung MS, Li MK, Chan TY The Chinese University of Hong Kong, Shatin, Hong Kong OBJECTIVES: Diabetes mellitus (DM) is a cluster of metabolic disorders, requiring chronic care. Cockram et al found that 1) a majority (62%) of those diagnosed with type 2 DM did not have access to programs providing patient education in Hong Kong, and 2) an alarming proportion (~50%) of patients with diabetes were not sufficiently informed about the risk of complications. The purpose of this study is to investigate the relationship of DM patients' medical knowledge and adherence to medical advice to their glycaemic control. METHODS: The study adopted the prospective, observational study design. Patients with DM who were followed up at the specialist outpatient clinic at the Princes of Wales Hospital were recruited. Two sets of Chinese questionnaires published in Yung et al were used to assess patients' 1) knowledge of DM, adherence to medical advice (maximum score = 10) and 2) knowledge of signs and symptoms of hypoglycaemic attacks (maximum score = 13). Demographic information, glycosylated haemoglobin A1C (HbA1C) levels and any previous history of hypoglycaemic attacks were recorded. Pearson product-moment correlation coefficients were used to identify the associations between knowledge, adherence to medical advice and glycaemic control (SPSS, 11.5.1, Chicago). RESULTS: A total of 178 medical records were screened and 119 patients (53% male; age: 62.2 ± 11.7 years old; mean duration of DM: 6.8 years) were recruited. The mean HbA1C level was 7.64 ± 1.55 %. The mean scores for the 2 questionnaires were 5.30 ± 1.88 and 4.29 ± 3.07 respectively. The correlation coefficients between the scores and the HbA1C levels were 0.024 and -0.061 respectively (P > 0.05). Patients with previous history of hypoglycaemic attach scored significantly higher in the second questionnaire (mean difference = -1.784, P = 0.003). CON-CLUSIONS: Patients' knowledge on DM and adherence to medical advice had no association with glycaemic control.
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PDB2 EVALUATION OF IMPROVED UTILITY ESTIMATES IN COST EFFECTIVENESS ANALYSIS OF MULTIPLE COMPLICATIONS IN TYPE-2 DIABETES
McEwan P 1 , Peters JR 2 , Currie CJ 2 1 University Hospital of Wales, Cardiff, Wales, UK; 2 Cardiff Research Consortium, Cardiff, Wales, UK OBJECTIVES: Several diabetes models have been developed to determine cost-effectiveness of therapy, some of which predict multiple complications. In these models, quality-adjusted life years (QALY's) have been estimated by multiplying health utility scores for individual complications, largely due to a lack of empirical data. This study evaluated the impact of this assumption using empirical utility values to model multiple complications in patients with type-2 diabetes. METHODS: This study used the Cardiff Stochastic Simulation Cost-Utility Model (DiabForecaster), which follows 10,000 newly diagnosed patients with type-2 diabetes over 20 years. We included the most reliable estimates of diabetes-related health utility scores using data from the Health Outcomes Data Repository (HODaR). The model employed baseline risk profiles used by Eastman. Utility scores were incorporated either multiplicatively (utility values for multiple complications were calculated by multiplying utility values for individual complications), or empirically (direct empirical data were used for patients with 1 and 2 complications and average utility decrements were used for subjects with ≥3 complications). QALY estimates were obtained assuming comprehensive (HbA1c = 7.2%) or standard care (HbA1c = 10%). The discount rate for benefit was 1.5%. RESULTS: There were 1965 (8.6%) patients with type-2 diabetes in HODaR. The overall mean utility for diabetic patients was 0.564 (SD ± 0.319) for males and 0.508 (SD ± 0.358) for females. This ranged from 0.716 (SD ± 0.267) in outpatients with no reported complications to 0.490 (SD ± 0.353) in those with ≥3 vascular events. Over 20 years, predicted QALYs ranged from a mean of 8.3 (multiplicative) to 8.9 per patient (empirical) assuming comprehensive care. Under standard care, the QALYS ranged from 6.8 (multiplicative) to 7.9 per patient (empirical). CONCLUSIONS: The model predicted variations >1 QALY depending on how the utility estimates were incorporated. The method chosen to value health utility for multiple complications in diabetes models can affect cost-effectiveness estimates of diabetes-related therapies. A recent clinical trial demonstrated non-inferiority in HbA1c and hypoglycaemic events with insulin detemir (IDet) compared to NPH in a basal/bolus regimen. Mean body weight in the IDet group increased less than the NPH group (0.4 Kg vs. 1.3 Kg respectively p = 0.017). The aim of this analysis was to use a validated diabetes model to link these short-term outcomes to long-term complication rates and associated UK health care costs, and to calculate the cost-effectiveness of treatment with IDet in type-2 diabetes. METHODS: A validated, non-proprietorial model, The Core Diabetes Model, was used to predict: long-term complications; improvements in Life Years
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